94 related articles for article (PubMed ID: 18620895)
1. Prognostic significance of 14-3-3sigma expression in oral squamous cell carcinoma (OSCC).
Laimer K; Blassnig N; Spizzo G; Kloss F; Rasse M; Obrist P; Schäfer G; Perathoner A; Margreiter R; Amberger A
Oral Oncol; 2009 Feb; 45(2):127-34. PubMed ID: 18620895
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas.
Laimer K; Troester B; Kloss F; Schafer G; Obrist P; Perathoner A; Laimer J; Brandacher G; Rasse M; Margreiter R; Amberger A
Oral Oncol; 2011 May; 47(5):352-7. PubMed ID: 21440489
[TBL] [Abstract][Full Text] [Related]
3. 14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients.
Perathoner A; Pirkebner D; Brandacher G; Spizzo G; Stadlmann S; Obrist P; Margreiter R; Amberger A
Clin Cancer Res; 2005 May; 11(9):3274-9. PubMed ID: 15867223
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of p63 is associated with radiation resistance and prognosis in oral squamous cell carcinoma.
Moergel M; Abt E; Stockinger M; Kunkel M
Oral Oncol; 2010 Sep; 46(9):667-71. PubMed ID: 20656547
[TBL] [Abstract][Full Text] [Related]
5. P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study.
Lo Muzio L; Campisi G; Farina A; Rubini C; Pannone G; Serpico R; Laino G; De Lillo A; Carinci F
BMC Cancer; 2005 Jun; 5():63. PubMed ID: 15967043
[TBL] [Abstract][Full Text] [Related]
6. Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.
Kumar M; Matta A; Masui O; Srivastava G; Kaur J; Thakar A; Shukla NK; RoyChoudhury A; Sharma M; Walfish PG; Michael Siu KW; Chauhan SS; Ralhan R
J Transl Med; 2015 Aug; 13():285. PubMed ID: 26318153
[TBL] [Abstract][Full Text] [Related]
7. High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.
Pukkila M; Kosunen A; Ropponen K; Virtaniemi J; Kellokoski J; Kumpulainen E; Pirinen R; Nuutinen J; Johansson R; Kosma VM
J Clin Pathol; 2007 Mar; 60(3):267-72. PubMed ID: 16731595
[TBL] [Abstract][Full Text] [Related]
8. The significance of p53 immunoexpression with different clones (DO-7 and PAb-240) in oral squamous cell carcinoma.
Silva Júnior Jde A; Camisasca DR; Bernardo V; Ribeiro GS; Dias FL; de Faria PA; de Amorim LM; Lourenço SQ
ORL J Otorhinolaryngol Relat Spec; 2013; 75(2):82-90. PubMed ID: 23817043
[TBL] [Abstract][Full Text] [Related]
9. FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?
Russo D; Merolla F; Mascolo M; Ilardi G; Romano S; Varricchio S; Napolitano V; Celetti A; Postiglione L; Di Lorenzo PP; Califano L; Dell'Aversana GO; Astarita F; Romano MF; Staibano S
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218707
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases.
Carlos de Vicente J; Junquera Gutiérrez LM; Zapatero AH; Fresno Forcelledo MF; Hernández-Vallejo G; López Arranz JS
Head Neck; 2004 Jan; 26(1):22-30. PubMed ID: 14724903
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of CD9 protein expression is associated with aggressive behavior of oral squamous cell carcinoma.
Buim ME; Lourenço SV; Carvalho KC; Cardim R; Pereira C; Carvalho AL; Fregnani JH; Soares FA
Oral Oncol; 2010 Mar; 46(3):166-71. PubMed ID: 20060356
[TBL] [Abstract][Full Text] [Related]
13. Expression of Eps8 correlates with poor survival in oral squamous cell carcinoma.
Chu PY; Liou JH; Lin YM; Chen CJ; Chen MK; Lin SH; Yeh CM; Wang HK; Maa MC; Leu TH; Chang NW; Hsu NC; Yeh KT
Asia Pac J Clin Oncol; 2012 Dec; 8(4):e77-81. PubMed ID: 22897151
[TBL] [Abstract][Full Text] [Related]
14. Immunoexpression and prognostic significance of TIMP-1 and -2 in oral squamous cell carcinoma.
de Vicente JC; Fresno MF; Villalain L; Vega JA; López Arranz JS
Oral Oncol; 2005 Jul; 41(6):568-79. PubMed ID: 15925538
[TBL] [Abstract][Full Text] [Related]
15. Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma.
Camisasca DR; Honorato J; Bernardo V; da Silva LE; da Fonseca EC; de Faria PA; Dias FL; Lourenço Sde Q
Oral Oncol; 2009 Mar; 45(3):225-33. PubMed ID: 18715811
[TBL] [Abstract][Full Text] [Related]
16. Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.
Cheng AN; Jiang SS; Fan CC; Lo YK; Kuo CY; Chen CH; Liu YL; Lee CC; Chen WS; Huang TS; Wang TY; Lee AY
Cancer Lett; 2013 Sep; 337(2):218-25. PubMed ID: 23684929
[TBL] [Abstract][Full Text] [Related]
17. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
18. High expression of Jun activation domain-binding protein 1 (Jab1) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.
Harada K; Kawashima Y; Yoshida H; Sato M
Anticancer Res; 2006; 26(2B):1615-9. PubMed ID: 16619581
[TBL] [Abstract][Full Text] [Related]
19. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
Nemes JA; Nemes Z; Márton IJ
J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070
[TBL] [Abstract][Full Text] [Related]
20. FAP-1 and NF-κB expressions in oral squamous cell carcinoma as potential markers for chemo-radio sensitivity and prognosis.
Nariai Y; Mishima K; Yoshimura Y; Sekine J
Int J Oral Maxillofac Surg; 2011 Apr; 40(4):419-26. PubMed ID: 21176871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]